> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Point-of-Care Coronavirus Test Authorized
- URL: https://www.fdaweb.com/point-of-care-coronavirus-test-authorized/
- Published: 2020-03-23T12:00:00.000Z
- Updated: 2026-09-14T16:08:27.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5146391

FDA has issued an emergency use authorization for Cepheid’s point-of-care coronavirus diagnostic, the [Cepheid Xpert Xpress SARS-CoV-2](https://c212.net/c/link/?t=0&l=en&o=2757776-1&h=3828934405&u=https%3A%2F%2Fwww.fda.gov%2Fmedia%2F136316%2Fdownload&a=Cepheid+Xpert+Xpress+SARS-CoV-2&ref=fdaweb.com) test, which can provide test results within hours instead of days current testing requires. The test is for use in high- and moderate-complexity [CLIA-certified](https://c212.net/c/link/?t=0&l=en&o=2757776-1&h=1410655555&u=https%3A%2F%2Fwww.fda.gov%2Fmedical-devices%2Fivd-regulatory-assistance%2Fclinical-laboratory-improvement-amendments-clia&a=CLIA-certified&ref=fdaweb.com) laboratories as well as in certain patient care settings. The company intends to roll-out availability of the point-of-care test by 3/30, FDA says.